Mason Morfit’s Liberty Live Group Series C LLYVK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$229M Sell
2,172,388
-1,388,820
-39% -$135M 4.07% 10
2026
Q1
$335M Sell
3,561,208
-42,780
-1% -$3.85M 5.87% 8
2025
Q4
$300M Buy
3,603,988
+88,100
+3% +$7.57M 4.27% 10
2025
Q3
$341M Sell
3,515,888
-476,000
-12% -$43M 5.75% 9
2025
Q2
$324M Buy
3,991,888
+88,000
+2% +$6.49M 5.79% 8
2025
Q1
$266M Buy
3,903,888
+735,100
+23% +$52.4M 5.81% 7
2024
Q4
$216M Buy
3,168,788
+1,831,288
+137% +$116M 4.91% 7
2024
Q3
$68.7M Buy
+1,337,500
New +$53.5M 1.57% 10

Other funds holding LLYVK

Mason Morfit's LLYVK Position: Q2 2026 in Review

Mason Morfit reduced its Liberty Live Group Series C (LLYVK) stake by 39% in Q2 2026, selling an estimated $135M and leaving 2,172,388 shares worth $229M. The position accounts for 4.07% of the portfolio, ranked #10.

Mason Morfit first reported a position in LLYVK in Q3 2024 and has held it in 8 quarters since. The position peaked at $341M in Q3 2025. 322 funds tracked by Wall St. Rank hold LLYVK as of Q2 2026.

  • Mason Morfit held 2,172,388 shares of Liberty Live Group Series C worth $229M as of Q2 2026.
  • Mason Morfit sold 1,388,820 Liberty Live Group Series C shares in Q2 2026, an estimated $135M.
  • Liberty Live Group Series C made up 4.07% of Mason Morfit's portfolio in Q2 2026, its #10 holding.
  • Mason Morfit first reported a position in Liberty Live Group Series C in Q3 2024 and has held it in 8 quarters since.
  • Mason Morfit's Liberty Live Group Series C position peaked at $341M in Q3 2025.
  • 322 funds tracked by Wall St. Rank held Liberty Live Group Series C as of Q2 2026.

Based on ValueAct Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.